Member Info for beinthelead

Nope. You’ve done a thorough job of exhausting that list.

Many have tried and failed. Somebody has said that, I’m sure. Was it you Rip? Could have been Alan.

People need to see past AVA6000. Think pathfinder. Pharma will not limit their interest to a Dox prodrug. There was a guy on Twitter (CLRB) the other night trying this exact angle.

He didn’t understand either.

Interesting post and view Luke. Can you give me some of those examples where others have proved FAP’s clinical utility in this way?

Got to love Mr A. Meltdown on Twitter because Myles doesn’t like him. Please like me Myles… very odd considering his accounts actively despise him.

Great find here by Tom. Thanks for sharing.

Urbansea - the data for C1-3 has been in hand for months. This is another plot on that graph.

This data should have been issued to shareholders in Q3. It wasn’t. Then Q4. It wasn’t. The placeholder was issued less than a month ago. AS’s call on timelines is atrocious. We deserve better and should not help via odd excuses.

The data will speak for itself.

Sure does. It just gets tedious, unreliable and unprofessional.

“People reading far too much in to ‘early January’ quote”

As in, reading the quote in the RNS? As in, expecting news because that’s what it said?

This board is nuts. AS has literally said an update was due early Jan. once again he disappoints. Yes, it’s coming… just keep your mouth shut.

Happy new year Rip/PL. Sorry, missed you early Jan.

Still… the wyndrum account makes one post and gone is the board. The account is a wind up and certainly boils the blood of most who read.

The only other poster this relentless against AVCT, with similar angles of attack is Quint. Eerily similar in their commitment.

Regardless, call it his fault or those of others who read and engage - wyn has managed to ‘own’ the board and destroy it. it’s difficult to ignore the posts when each legitimate discussion is infected by him.

I’ve tried filtering. Tried not getting annoyed by the abusive manipulation - I struggle to walk by while others are being manipulated. I despise bullies/charlatans.

My ‘protest’ against LSE if you like (as it’s their fault) is to leave. New Year and all that… well done Wyndrum. You’ve spoiled it.

All the best to the majority of the board. We’re nearly there. 2023 will be interesting.

Molecular partners.

Hugely different approach. They bind, we cleave. We give a decades old drug (dox) a piggy back and dump it in the tumour to destroy it. Kill it.

They rely on immune response.

We should need P2 only, and it’s a platform that can be adapted to a host of other drugs.

Simpler than that Rip - nobody would listen. They’d take absolutely no notice and crack on. The mood music has changed. People have had enough of the government eroding every last penny of their salary and pension.

It’s done.

Avacta isn’t a Covid stock. It never has been. Look at the ABDX chart and it’s a sorry state. The big con.

Rip - A small contribution to your sterling services.

RAH - absolutely. The MoA wasn’t a failure, just misunderstood, hence why oncology is now taking it further. I didn’t feel the need to give Derek any more free research to deramp.

Derek;

Matthew Vincent worked at ocata before Arisaph. Ocata is now Atellas. Royalty Pharma acquired patent rights/licenses for DPP4 inhibitors from both. Validating their utility.

Matthew Vincent monetised that tech to the sum of $100m to Arisaph. A private company. A company essentially holding a patent.

Val-boro-pro (Talabostat) is the commercialised DPP4 inhibitor developed by Bachovchin.

His tech works.

By all means, come back in 2 years time and deramp P2 as there’s more risk and more scope to scaremonger. You’re wasting your time here.

You add nothing. You have next to no knowledge.

Rip - I’ll be there. Hook or crook.

No they don’t have a working version for Omicron. The test is a dud. We were told this nearly 12 months ago.

PL’s deramping is correct. He’s nearly as bad as me. Less miserable and correct most of the time.

Rip - Exactly that.

There’s nothing much to say until news. Amazing how boring the wait is to be honest.

We’ve had RNSs all year telling us when the readout will land. He’s missed every one. The only difference here is the ~6 week backstop he’s given himself to slip again.

That backstop is a science day that is highly likely to discuss/articulate what the “excellent” data means to the market.

This isn’t the LFT and omicron. That was a qualitative assessment and it’s wasn’t hitting the mark, when others ‘were’.

C1-3 have been a resounding success. Even if C4 has broken the DLTs and an MTD has been reached, that’s still ‘good’ news. Again, we are expecting a successful P1 trial because it HAS been successful.

There has been no build up in the SP before, literally boring. Nobody interested. LTHs have done every ounce of research and will wait. Traders will be trading their 95 pot between now and news.

This stock needs new money and a refresh. It’ll land in Feb.

Still hasn’t bought any though.

Can’t imagine how much excited he gets when actually buying something.

He’s paid to cover and uses Avacta’s social media following to grab business. Great to get coverage, but pretty self indulgent.

Not until it’s concluded and analysed. That the luxury they have in terms of forecasting/strategic planning.

AS said “full technical update…” re Q4 TMAC update. They absolutely do the have data to confirm TMAC is a worthy pursuit, but they may have decided to wrap it up as a big reveal. After all, the TMAC programme is the jewel. The ADC market disruptor (precision is a bit on its own) is worth multiples of AVA, as you know.

If AS is good at anything, it’s selling the dream. He’s first class. I’m working on that ‘City Boy’ disguise* in prep for the 23rd. Should be one for the ages.

*Financial kind, not of 5705 fame.

You didn’t imagine it Rip. I have the same memory. Or is it the Mandela effect??!!

Q4 for TMAC update. However, this is almost certainly rolled into the FEB date now. My joker is an update from the Dx division this Q. I think we see something.

Rip - I’ll be there in my lab coat. I’ll get them in.